NASDAQ
Mersana Therapeutics, Inc. (MRSN) has a fcf yield of -47.06% as of Friday, May 29, 2026. This represents a 71.89% decrease compared to its 12-month average of -27.38%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.
No price data available for this timeframe.